Evidence map›Paper›PMID 36788538›Full record

ArticleJournal of translational medicine2023

Hepatocyte SGK1 activated by hepatic ischemia-reperfusion promotes the recurrence of liver metastasis via IL-6/STAT3.

Xiangdong Li, Ziyi Wang, Chenyu Jiao, Yu Zhang, Nan Xia, Wenjie Yu, Xuejiao Chen, Likalamu Pascalia Wikana, Yue Liu, Linfeng Sun and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Characterizing risk groups in papillary thyroid carcinoma through T-Cell mediated tumor cell killing-related genes: a pathway to therapeutic predictions.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Xiangdong Li *Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ziyi Wang *Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chenyu Jiao *Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yu ZhangHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Nan XiaHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wenjie YuHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xuejiao ChenDepartment of General Surgery, Affiliated Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, China.
Likalamu Pascalia WikanaHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yue LiuDepartment of General Surgery, Affiliated Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, China.
Linfeng SunHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Minhao ChenHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yuhao XiaoHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yuhua ShiDepartment of General Surgery, Affiliated Yancheng School of Clinical Medicine of Nanjing Medical University, Yancheng, China. 15189200688@163.com.
Sheng HanHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. hanshengss@163.com.
Liyong PuHepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. puliyong@njmu.edu.cn.ORCID 0000-0002-2119-3193
Chinese Academy of Medical Sciences & Peking Union Medical College · CNNanjing Medical University · CNYancheng Third People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiver metastasis is the leading cause of death in patients with colorectal cancer (CRC). Surgical resection of the liver metastases increases the incidence of long-term survival in patients with colorectal liver metastasis (CRLM). However, many patients experience CRLM recurrence after the initial liver resection. As an unavoidable pathophysiological process in liver surgery, liver ischemia-reperfusion (IR) injury increases the risk of tumor recurrence and metastasis.

methodsColorectal liver metastasis (CRLM) mouse models and mouse liver partial warm ischemia models were constructed. The levels of lipid peroxidation were detected in cells or tissues. Western Blot, qPCR, elisa, immunofluorescence, immunohistochemistry, scanning electron microscope, flow cytometry analysis were conducted to evaluate the changes of multiple signaling pathways during CRLM recurrence under liver ischemia-reperfusion (IR) background, including SGK1/IL-6/STAT3, neutrophil extracellular traps (NETs) formation, polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC) infiltration.

resultsHepatocyte serum/glucocorticoid regulated kinase 1 (SGK1) was activated in response to hepatic ischemia-reperfusion injury to pass hepatocyte STAT3 phosphorylation and serum amyloid A (SAA) hyperactivation signals in CRLM-IR mice, such regulation is dependent on SGK-activated IL-6 autocrine. Administration of the SGK1 inhibitor GSK-650394 further reduced ERK-related neutrophil extracellular traps (NETs) formation and polymorphonucler myeloid-derived suppressor cells (PMN-MDSC) infiltration compared with targeting hepatocyte SGK1 alone, thereby alleviating CRLM in the context of IR.

conclusionsOur study demonstrates that hepatocyte and immune cell SGK1 synergistically promote postoperative CRLM recurrence in response to hepatic IR stress, and identifies SGK1 as a translational target that may improve postoperative CRLM recurrence.

Indexed as

Colorectal NeoplasmsLiver NeoplasmsProtein Serine-Threonine KinasesReperfusion InjuryAnimalsHepatocytesInterleukin-6IschemiaLiverMiceNeoplasm Recurrence, LocalSerum-Glucocorticoid Regulated KinasesSTAT3 Transcription FactorInterleukin-6interleukin-6, mouseProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated KinasesStat3 protein, mouseSTAT3 Transcription FactorHepatic ischemia reperfusionNRF2SGK1STAT3Tumor recurrence

Identifiers

PMID36788538
PMCPMC9926712
OpenAlexW4320727335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.